基于世界卫生组织2021分类的125例新诊断成人型弥漫性胶质瘤患者治疗前11C-蛋氨酸正电子发射断层扫描指标与组织学及预后的关联
本研究纳入125例新诊断成人型弥漫性胶质瘤患者,比较11C-蛋氨酸PET指标(SUVmax、TNR、MTV、TLMU)与组织学和遗传学特征,并评估93例手术患者的预后。结果显示MET-PET指标可反映组织学亚型、WHO分级和预后,但少突胶质肿瘤除外;容积参数与复发无显著关联,而SUVmax和TNR与复发相关。
要点
- IDH野生型成人型弥漫性胶质瘤的MET-PET各项指标均显著高于IDH突变型(P<0.05)。
- IDH突变型星形细胞瘤G4的SUVmax、MTV和TLMU显著高于G2/3星形细胞瘤(P<0.05)。
- 复发患者的SUVmax和TNR显著高于非复发患者(P<0.01),MTV和TLMU无显著差异。
核心结论
- 基于WHO 2021分类,MET-PET指标能较好地反映成人型弥漫性胶质瘤的组织学亚型、WHO分级和预后,但少突胶质肿瘤除外。
- 与SUVmax和TNR不同,容积参数与复发无显著关联。
研究设计与样本
- 共纳入125例新诊断成人型弥漫性胶质瘤患者,比较MET-PET指标与组织学和遗传学特征。
- 评估了93例接受手术治疗的患者的预后。
主要发现
- IDH野生型患者MET-PET各项参数均显著高于IDH突变型患者(P<0.05),且总生存期和无进展生存期均显著更短(两者P<0.0001)。
- 在IDH突变型组中,IDH突变型星形细胞瘤G4患者的SUVmax、MTV和TLMU显著高于IDH突变型星形细胞瘤G2/3患者(P<0.05),但与G2-3少突胶质细胞瘤患者相比无显著差异。
- IDH突变型星形细胞瘤G4患者的无进展生存期显著短于G2/3星形细胞瘤和G3少突胶质细胞瘤患者(两者P<0.05)。
- 复发患者的SUVmax和TNR显著高于非复发患者(两者P<0.01),而MTV和TLMU无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify the relationships between 11C-methionine (MET) positron emission tomography (PET) metrics and the histology, genetics, and prognosis of adult-type diffuse glioma (ADG) based on the World Health Organization (WHO) 2021 classification. METHODS: A total of 125 newly diagnosed patients with ADG were enrolled. We compared the maximum standardized uptake value (SUVmax), tumor-to-normal background ratio (TNR), metabolic tumor volume (MTV), and total lesion methionine uptake (TLMU) to the histology and genetics of the patients with ADG. We also evaluated the prognoses of the 93 surgically treated patients. RESULTS: The patients with isocitrate dehydrogenase wild ADG showed significantly higher MET-PET metrics (P < 0.05 for all parameters), significantly shorter overall survival and progression-free survival (P < 0.0001 for both) than those of the patients with isocitrate dehydrogenase mutant (IDHm) ADG. In the IDHm ADG group, the SUVmax, MTV, and TLMU values were significantly higher in patients with IDHm grade (G) 4 astrocytoma than patients with IDHm G2/3 astrocytoma (P < 0.05 for all), but not than patients with G2-3 oligodendroglioma. The progression-free survival was significantly shorter in the patients with G4 astrocytoma versus the patients with G2/3 astrocytoma and G3 oligodendroglioma (P < 0.05 for both). The SUVmax and TNR values were significantly higher in recurrent patients than nonrecurrent patients (P < 0.01 for both), but no significant differences were found in MTV or TLMU values. CONCLUSIONS: MET-PET metrics well reflect the histological subtype, WHO grade and prognosis of ADG based on the 2021 WHO classification, with the exception of oligodendroglial tumors. Volumetric parameters were not significantly associated with recurrence, unlike the SUVmax and TNR.
引用
- Kaneko K, Koriyama S, Tsuzuki S, et al. Association Between Pretreatment 11C-Methionine Positron Emission Tomography Metrics, Histology, and Prognosis in 125 Newly Diagnosed Patients with Adult-Type Diffuse Glioma Based on the World Health Organization 2021Classification. World Neurosurg. 2024. PMID: 38583563. doi:10.1016/j.wneu.2024.03.164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。